|
NMI expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.221900E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.075800E-01 |
| Normal-vs-Stage2 |
2.97859999998096E-06 |
| Normal-vs-Stage3 |
5.193600E-02 |
| Normal-vs-Stage4 |
7.647700E-02 |
| Stage1-vs-Stage2 |
1.60908999999876E-05 |
| Stage1-vs-Stage3 |
1.716000E-01 |
| Stage1-vs-Stage4 |
1.883200E-01 |
| Stage2-vs-Stage3 |
3.208500E-04 |
| Stage2-vs-Stage4 |
1.896320E-02 |
| Stage3-vs-Stage4 |
7.024800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.284830E-01 |
| Normal-vs-AfricanAmerican |
8.522000E-03 |
| Normal-vs-Asian |
4.769800E-01 |
| Caucasian-vs-AfricanAmerican |
4.149700E-02 |
| Caucasian-vs-Asian |
7.003800E-01 |
| AfricanAmerican-vs-Asian |
6.788400E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.109500E-02 |
| Normal-vs-Female |
4.876500E-02 |
| Male-vs-Female |
6.044000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.628400E-01 |
| Normal-vs-Age(41-60Yrs) |
2.771700E-02 |
| Normal-vs-Age(61-80Yrs) |
4.556700E-04 |
| Normal-vs-Age(81-100Yrs) |
5.116400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.941900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.599600E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.607000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.433500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.862800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.995400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.793600E-01 |
| Classical-VS-Follicular |
4.16110479406484E-11 |
| Classical-VS-Other |
8.048000E-02 |
| Classical-VS-Normal |
4.413600E-01 |
| Tall-VS-Follicular |
3.94690000005138E-06 |
| Tall-VS-Other |
3.099600E-02 |
| Tall-VS-Normal |
9.312000E-01 |
| Follicular-VS-Other |
6.572800E-01 |
| Follicular-VS-Normal |
3.98930000145015E-08 |
| Other-VS-Normal |
2.472500E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.206380E-02 |
| Normal-vs-N1 |
3.730000E-02 |
| N0-vs-N1 |
9.750400E-01 |
|
|
